PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+2.96%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$460M
AUM Growth
+$84.2M
(+22%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
22.41%
Top 10 Holdings %
Top 10 Hldgs %
34.98%
Holding
99
New
18
Increased
56
Reduced
8
Closed
16
Top Buys
| 1 |
Cooper Companies
COO
|
$15.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$10.3M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$10.2M |
| 4 |
Becton Dickinson
BDX
|
$9.85M |
| 5 |
Zimmer Biomet
ZBH
|
$8.4M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$14.7M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$7.03M |
| 3 |
Danaher
DHR
|
$5.84M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$4.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$4.58M |
Sector Composition
| 1 | Healthcare | 99.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
26
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $7.14M | 1.55% |
39,307
+20,407
| +108% | +$3.71M |
|
27
RxSight
RXST
$372M
| $7.14M | 1.55% |
427,793
+251,372
| +142% | +$4.19M |
|
28
Vaxcyte
PCVX
$4.29B
| $6.97M | 1.52% |
186,097
+28,049
| +18% | +$1.05M |
|
29
Natera
NTRA
$23.1B
| $6.94M | 1.51% |
125,043
+71,551
| +134% | +$3.97M |
|
30
Madrigal Pharmaceuticals
MDGL
$9.66B
| $6.26M | 1.36% |
25,840
+18,499
| +252% | +$4.48M |
|
31
Evolent Health
EVH
$1.1B
| $6.07M | 1.32% |
+186,923
| New | +$6.07M |
|
32
MannKind Corp
MNKD
$1.72B
| $6.04M | 1.31% |
1,474,098
+442,989
| +43% | +$1.82M |
|
33
Ionis Pharmaceuticals
IONS
$9.76B
| $5.4M | 1.18% |
151,161
+10,046
| +7% | +$359K |
|
34
Day One Biopharmaceuticals
DAWN
$769M
| $5.35M | 1.16% |
400,220
+175,737
| +78% | +$2.35M |
|
|
PHLT
35
Performant Healthcare, Inc. Common Stock
PHLT
$604M
| $5.28M | 1.15% |
1,553,875
+234,200
| +18% | +$796K |
|
36
Sutro Biopharma
STRO
$89M
| $5.08M | 1.11% |
1,100,038
+234,063
| +27% | +$1.08M |
|
37
Biogen
BIIB
$20.8B
| $4.98M | 1.08% |
17,920
+2,703
| +18% | +$752K |
|
38
Supernus Pharmaceuticals
SUPN
$2.57B
| $4.78M | 1.04% |
131,878
+36,972
| +39% | +$1.34M |
|
39
Arcellx
ACLX
$3.98B
| $4.55M | 0.99% |
147,646
+26,553
| +22% | +$818K |
|
40
TG Therapeutics
TGTX
$5.03B
| $4.15M | 0.9% |
+275,641
| New | +$4.15M |
|
41
ANI Pharmaceuticals
ANIP
$2.05B
| $3.97M | 0.86% |
100,000
-26,874
| -21% | -$1.07M |
|
|
42
Danaher
DHR
$143B
| $3.84M | 0.83% |
17,164
-26,143
| -60% | -$5.84M |
|
43
89bio
ETNB
$1.3B
| $3.76M | 0.82% |
246,956
-85,924
| -26% | -$1.31M |
|
44
Waters Corp
WAT
$18.1B
| $3.67M | 0.8% |
11,867
+3,063
| +35% | +$948K |
|
45
KORU Medical Systems
KRMD
$188M
| $3.59M | 0.78% |
851,375
+128,319
| +18% | +$542K |
|
46
Travere Therapeutics
TVTX
$1.95B
| $3.19M | 0.69% |
141,887
+119,052
| +521% | +$2.68M |
|
|
BCYC
47
Bicycle Therapeutics
BCYC
$491M
| $3.14M | 0.68% |
147,799
+56,467
| +62% | +$1.2M |
|
48
Esperion Therapeutics
ESPR
$528M
| $2.99M | 0.65% |
1,878,857
+1,056,073
| +128% | +$1.68M |
|
49
Immunovant
IMVT
$2.93B
| $2.89M | 0.63% |
186,045
+28,039
| +18% | +$435K |
|
50
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $2.69M | 0.59% |
250,257
+58,950
| +31% | +$634K |
|